the authors report the results of a randomized study conducted to evaluate the relative benefit of treatment with 1,3-bis ( 2-chloroethyl ) -1-nitrosourea ( bcnu ) or the combination of procarbazine , 1- ( 2-chloroethyl ) -3-cyclohexyl-1-nitrosourea , and vincristine ( pcv ) administered after radiation therapy with hydroxyurea to 76 evaluable patients with glioblastoma multiforme and 72 patients with other anaplastic gliomas .
C0007257
bcnu
C0017636
glioblastoma multiforme